Clinical relevance, mechanisms, and evolution of polymyxin B heteroresistance carbapenem-resistant Klebsiella pneumoniae: A genomic, retrospective cohort study
Clinical Microbiology and Infection · 2024
DOI: 10.1016/j.cmi.2024.01.014 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Clinical Microbiology and Infection, 2024. Verfasst von Qixia Luo und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Di…. Hauptthemen laut MEDLINE: Carbapenem-Resistant Enterobacteriaceae, Klebsiella Infections. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, National Health Commission of the People's Republic of China, Zhejiang Province Natural Science Foundation.
Abstract (Originalsprache)
OBJECTIVES: To study the clinical relevance, mechanisms, and evolution of polymyxin B (POLB) heteroresistance (PHR) in carbapenem-resistant Klebsiella pneumoniae (CRKP), potentially leading to a significant rise in POLB full resistant (FR) CRKP. METHODS: Total of 544 CRKP isolates from 154 patients treated with POLB were categorized into PHR and POLB non-heteroresistance (NHR) groups. We performed statistical analysis to compare clinical implications and treatment responses. We employed whole-genome sequencing, bioinformatics, and PCR to study the molecular epidemiology, mechanisms behind PHR, and its evolution into FR. RESULTS: We observed a considerable proportion (118 of 154, 76.62%) of clinically undetected PHR strains before POLB exposure, with a significant subset of them (33 of 118, 27.97%) evolving into FR after POLB treatment. We investigated the clinical implications, epidemiological characteristics, mechanisms, and evolutionary patterns of PHR strains in the context of POLB treatment. About 92.86% (39 of 42) of patients had PHR isolates before FR, highlighting the clinical importance of PHR. the ST15 exhibited a notably lower PHR rate (1 of 8, 12.5% vs. 117 of 144, 81.25%; p < 0.01). The ST11 PHR strains showing significantly higher rate of mgrB mutations by endogenous insertion sequences in their resistant subpopulation (RS) compared with other STs (78 of 106, 73.58% vs. 4 of 12, 33.33%; p < 0.01). The mgrB insertional inactivation rate was lower in FR isolates than in the RS of PHR isolates (15 of 42, 35.71% vs. 84 of 112, 75%; p < 0.01), whereas the pmrAB mutation rate was higher in FR isolates than in the RS of PHR isolates (8 of 42, 19.05% vs. 2 of 112, 1.79%; p < 0.01). The evolution from PHR to FR was influenced by subpopulation dynamics and genetic adaptability because of hypermutability. DISCUSSION: We highlight significant genetic changes as the primary driver of PHR to FR in CRKP, underscoring polymyxin complexity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of M…
Förderung
- National Natural Science Foundation of China
- National Health Commission of the People's Republic of China
- Zhejiang Province Natural Science Foundation
Zitieren
APA
Luo, Q., Xu, L., Wang, Y., Fu, H., Xiao, T., Yu, W., Zhou, W., Zhang, K., Shen, J., Ji, J., Ying, C., & Xiao, Y. (2024). Clinical relevance, mechanisms, and evolution of polymyxin B heteroresistance carbapenem-resistant Klebsiella pneumoniae: A genomic, retrospective cohort study. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2024.01.014
Vancouver
Luo Q, Xu L, Wang Y, Fu H, Xiao T, Yu W, et al. Clinical relevance, mechanisms, and evolution of polymyxin B heteroresistance carbapenem-resistant Klebsiella pneumoniae: A genomic, retrospective cohort study. Clinical Microbiology and Infection. 2024. doi:10.1016/j.cmi.2024.01.014
BibTeX
@article{Luo2024,
author = {Luo, Qixia and Xu, Linna and Wang, Yuan and Fu, Hao and Xiao, Tingting and Yu, Wei and Zhou, Wangxiao and Zhang, Kanghui and Shen, Jiaying and Ji, Jinru and Ying, Chaoqun and Xiao, Yonghong},
title = {Clinical relevance, mechanisms, and evolution of polymyxin B heteroresistance carbapenem-resistant Klebsiella pneumoniae: A genomic, retrospective cohort study},
journal = {Clinical Microbiology and Infection},
year = {2024},
doi = {10.1016/j.cmi.2024.01.014}
}
EUVIMED